Munich Remote SpO2 and Heart Rate Assessment in Covid-19 patients (COVID SMART vormals MR SPOC)

Most people infected with SARS-CoV-2 initially start the disease in quarantine at home. Especially in people with risk factors or pre-existing conditions, the state can worsen later, sometimes almost unnoticed.

In the COVID SMART study (Munich Remote SpO2 and Heart Rate Assessment in Covid-19 patients), the affected patients are equipped with modern smartwatches that continuously measure ECG, pulse, and oxygen saturation in the blood. If the condition worsens, the patient can use his or her data to obtain telemedical advice via a 24-hour medical hotline to determine whether hospitalization is necessary. COVID-19 patients get into the hospital in time, but avoid unnecessary hospital stays - and the healthcare system is also relieved.

COVID SMART - Munich Remote SpO2 and Heart Rate Assessment in Covid-19 patients (COVID SMART vormals MR SPOC)

Publications

Telemedical management of symptomatic Covid-19 outpatients. Von Falkenhausen, Sinner et al.. ERJ Open Research 2024; DOI: 10.1183/23120541.00277-2024

Principal Investigators

Principal investigator: Moritz Sinner (München)

Press releases and news

10.09.2024
[Translate to English:] Porträt von PD Dr. Moritz Sinner, LMU Klinikum München
 
29.03.2021
COVID SMART study key visual
 
16.09.2020
 

Study information
COVID SMART

Recruiting status
Study completed
Recruitment start
09.2020
Clinical Trials Registrierung

NCT04471636

Category
Early clinical study
DZHK Funding
€ 146.032
Links
https://covid-smart.de/

Operative contact:
Main study centre - Moritz Sinner, MD
msinner@med.lmu.de